Infarction Patterns and Recurrent Adverse Cerebrovascular Events in Moyamoya Disease.
Yu SC, Yin ZH, Zeng CF, Lin F, Ma L, Zhang Y, Zhang D, Zhao JZ.
Dis Markers. 2022 Mar 29;2022:8255018. doi: 10.1155/2022/8255018. eCollection 2022.
Lipoprotein (a) and cerebrovascular disease.
Kosmas CE, Bousvarou MD, Papakonstantinou EJ, Zoumi EA, Rallidis LS.
J Int Med Res. 2024 Jul;52(7):3000605241264182. doi: 10.1177/03000605241264182.
What are the causes of late-life depression?
Aziz R, Steffens DC.
Psychiatr Clin North Am. 2013 Dec;36(4):497-516. doi: 10.1016/j.psc.2013.08.001. Epub 2013 Oct 6.
Cerebrovascular disease in women.
Knepper LE, Giuliani MJ.
Cardiology. 1995;86(4):339-48. doi: 10.1159/000176898.
Cerebral microbleeds and cognition in cerebrovascular disease: an update.
Charidimou A, Werring DJ.
J Neurol Sci. 2012 Nov 15;322(1-2):50-5. doi: 10.1016/j.jns.2012.05.052. Epub 2012 Jun 18.
Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study.
Wang Y, Zhao X, Liu L, Soo YO, Pu Y, Pan Y, Wang Y, Zou X, Leung TW, Cai Y, Bai Q, Wu Y, Wang C, Pan X, Luo B, Wong KS; CICAS Study Group.
Stroke. 2014 Mar;45(3):663-9. doi: 10.1161/STROKEAHA.113.003508. Epub 2014 Jan 30.
[Cerebrovascular disease in the tropics].
del Brutto OH.
Rev Neurol. 2001 Oct 16-31;33(8):750-62.
MRI in the management of cerebrovascular disease to prevent stroke.
Thulborn KR.
Neurol Clin. 2008 Nov;26(4):897-921, vii-viii. doi: 10.1016/j.ncl.2008.08.001.
Ischemic stroke recurrence and mortality in different imaging phenotypes of ischemic cerebrovascular disease: The SMART-MR Study.
Lucci C, Rissanen I, de Jong PA, Kappelle LJ, Hendrikse J, Geerlings MI.
Eur Stroke J. 2023 Jun;8(2):522-531. doi: 10.1177/23969873231162122. Epub 2023 Mar 10.
Headache in cerebrovascular disease.
Portenoy RK, Abissi CJ, Lipton RB, Berger AR, Mebler MF, Baglivo J, Solomon S.
Stroke. 1984 Nov-Dec;15(6):1009-12. doi: 10.1161/01.str.15.6.1009.
